Jones M - Search Results

1

The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes.

Johnson RJ, Stack M, Hazlewood SA, Jones M, Blackmore CG, Hu LF, Rowe M. Johnson RJ, et al. Among authors: jones m. J Virol. 1998 May;72(5):4038-48. doi: 10.1128/JVI.72.5.4038-4048.1998. J Virol. 1998. PMID: 9557692 Free PMC article.

2

The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules.

Keating S, Prince S, Jones M, Rowe M. Keating S, et al. Among authors: jones m. J Virol. 2002 Aug;76(16):8179-88. doi: 10.1128/jvi.76.16.8179-8188.2002. J Virol. 2002. PMID: 12134023 Free PMC article.

3

Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions.

Floettmann JE, Eliopoulos AG, Jones M, Young LS, Rowe M. Floettmann JE, et al. Among authors: jones m. Oncogene. 1998 Nov 5;17(18):2383-92. doi: 10.1038/sj.onc.1202144. Oncogene. 1998. PMID: 9811470

4

Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.

Fielding CA, Sandvej K, Mehl A, Brennan P, Jones M, Rowe M. Fielding CA, et al. Among authors: jones m. J Virol. 2001 Oct;75(19):9129-41. doi: 10.1128/JVI.75.19.9129-9141.2001. J Virol. 2001. PMID: 11533177 Free PMC article.

5

Mechanism of action of a novel latent membrane protein-1 dominant negative.

Brennan P, Floettmann JE, Mehl A, Jones M, Rowe M. Brennan P, et al. Among authors: jones m. J Biol Chem. 2001 Jan 12;276(2):1195-203. doi: 10.1074/jbc.M005461200. J Biol Chem. 2001. PMID: 11031256 Free article.

6

Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription.

Mehl AM, Floettmann JE, Jones M, Brennan P, Rowe M. Mehl AM, et al. Among authors: jones m. J Biol Chem. 2001 Jan 12;276(2):984-92. doi: 10.1074/jbc.M003758200. J Biol Chem. 2001. PMID: 11034993 Free article.

7

Detection of EBV latent proteins by western blotting.

Rowe M, Jones M. Rowe M, et al. Among authors: jones m. Methods Mol Biol. 2001;174:229-42. doi: 10.1385/1-59259-227-9:229. Methods Mol Biol. 2001. PMID: 11357649 No abstract available.

8

Characterization of a CD40-dominant inhibitory receptor mutant.

Mehl AM, Jones M, Rowe M, Brennan P. Mehl AM, et al. Among authors: jones m. J Immunol. 2001 Dec 1;167(11):6388-93. doi: 10.4049/jimmunol.167.11.6388. J Immunol. 2001. PMID: 11714804

9

Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells.

Brennan P, Mehl AM, Jones M, Rowe M. Brennan P, et al. Among authors: jones m. Oncogene. 2002 Feb 14;21(8):1263-71. doi: 10.1038/sj.onc.1205182. Oncogene. 2002. PMID: 11850846

10

Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.

Evans M, Borysiewicz LK, Evans AS, Rowe M, Jones M, Gileadi U, Cerundolo V, Man S. Evans M, et al. Among authors: jones m. J Immunol. 2001 Nov 1;167(9):5420-8. doi: 10.4049/jimmunol.167.9.5420. J Immunol. 2001. PMID: 11673561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,334 results

Search Page

Filters